- Home
- QGEN vs LEVI Comparison
QGEN vs LEVI Comparison
Compare QGEN & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QGEN | LEVI |
|---|---|---|
| Founded | 1986 | 1853 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 9.1B |
| IPO Year | 1996 | 2019 |
Fundamental Metrics
Financial Performance| Metric | QGEN | LEVI |
|---|---|---|
| Price | $50.85 | $21.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $51.30 | $26.31 |
| AVG Volume (30 Days) | ★ 3.6M | 2.9M |
| Earning Date | 02-04-2026 | 01-28-2026 |
| Dividend Yield | ★ 4.72% | 2.54% |
| EPS Growth | ★ 409.76 | 178.65 |
| EPS | ★ 2.04 | 1.45 |
| Revenue | $2,089,999,000.00 | ★ $6,282,000,000.00 |
| Revenue This Year | $7.75 | $7.62 |
| Revenue Next Year | $6.13 | $5.31 |
| P/E Ratio | $25.00 | ★ $15.21 |
| Revenue Growth | ★ 5.65 | 4.14 |
| 52 Week Low | $39.61 | $12.17 |
| 52 Week High | $57.82 | $24.82 |
Technical Indicators
Market Signals| Indicator | QGEN | LEVI |
|---|---|---|
| Relative Strength Index (RSI) | 51.67 | 56.78 |
| Support Level | $50.53 | $19.19 |
| Resistance Level | $51.71 | $20.75 |
| Average True Range (ATR) | 1.27 | 0.80 |
| MACD | -0.47 | 0.19 |
| Stochastic Oscillator | 24.69 | 75.93 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About LEVI Levi Strauss & Co
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.